Herbs (Global Traditional) · Ayurveda
Trikatu (Piper longum, Piper nigrum, Zingiber officinale)
Moderate Evidencebotanical1 PubMed Study
Hermetica Superfood Encyclopedia
Trikatu is an Ayurvedic formula combining black pepper (Piper nigrum), long pepper (Piper longum), and ginger (Zingiber officinale). The piperine and gingerol compounds work synergistically to enhance bioavailability, reduce inflammation, and support digestive function.
Trikatu is a traditional Ayurvedic herbal formulation consisting of three spices in equal parts: Piper longum (long pepper fruit), Piper nigrum (black pepper fruit), and Zingiber officinale (ginger rhizome). Native to South Asia, it is prepared by drying, grinding, and mixing these raw materials into a powder, though modern formulations may use simple powdering or water decoctions.
No human clinical trials, RCTs, or meta-analyses on Trikatu were identified; all evidence comes from preclinical animal studies. A 2021 review (PMID: 34081846) proposed Trikatu for flu/COVID-19 based on anti-inflammatory effects in preclinical models but emphasized the need for human RCTs.
Human dosage data is absent; only animal studies are available. In rat studies, doses ranged from 5-300 mg/kg body weight daily for 28 days (liver models) to 1000 mg/kg for 30 days (arthritis models). Consult a healthcare provider before starting any new supplement.
Trikatu is a classical Ayurvedic formulation combining equal parts of three pungent herbs: Piper longum (Long pepper), Piper nigrum (Black pepper), and Zingiber officinale (Ginger). As a medicinal preparation rather than a primary food source, its nutritional significance lies predominantly in bioactive compounds rather than macronutrient content. **Key Bioactive Compounds:** Piper longum: Piperine (1-2% in fruit), piperlongumine (0.1-0.5%), pellitorine, piperlonguminine, and various amides. Also contains essential oils (~1%) including caryophyllene and bisabolene. Piper nigrum: Piperine (5-9% in black pepper), chavicine, piperidine, essential oils (1.5-2.5% including sabinene, limonene, beta-caryophyllene), and minor alkaloids including piperyline and piperamine. Zingiber officinale: Gingerols (primarily 6-gingerol, ~0.5-1% in fresh rhizome), shogaols (formed upon drying, ~0.3-0.7%), zingerone, paradols, zingiberene (~30-35% of essential oil), and beta-bisabolene. **Macronutrients (per 100g dry powder, approximate combined blend):** Carbohydrates: 60-65g Dietary fiber: 12-18g Protein: 5-8g Fat: 5-8g (including fixed and volatile oils) Moisture: 8-12% **Micronutrients (approximate):** Manganese: 15-25mg (significant contribution) Iron: 8-15mg Calcium: 200-400mg Magnesium: 100-150mg Potassium: 800-1200mg Vitamin C: 10-30mg (largely degraded in dried preparations) Vitamin B6: 0.5-1.2mg Zinc: 1.5-3mg Copper: 0.5-1.0mg Phosphorus: 150-250mg **Bioavailability Notes:** Piperine from Piper longum and Piper nigrum is the primary bioavailability-enhancing constituent; it inhibits CYP3A4 and P-glycoprotein efflux transporters and intestinal glucuronidation, increasing absorption of co-administered compounds (e.g., curcumin bioavailability enhanced by up to 2000% at 20mg piperine co-administration). Gingerols and shogaols exhibit moderate oral bioavailability (~10-30%) due to first-pass metabolism; shogaols demonstrate superior bioavailability compared to gingerols. The thermogenic properties of the combination synergistically enhance digestive enzyme secretion, improving overall nutrient absorption. Lipophilic bioactives (piperine, gingerols) benefit from co-administration with dietary fats. Trikatu is traditionally administered with honey or ghee to further enhance absorption of its fat-soluble constituents. Piperine concentration is critical; significant batch-to-batch variability (5-25% variation) is reported depending on botanical source and processing method.
Piperine from both pepper species inhibits cytochrome P450 enzymes and P-glycoprotein transporters, enhancing absorption of other compounds. Gingerol from ginger modulates COX-2 and 5-LOX enzymes while suppressing NF-κB pathway activation. The combination creates synergistic effects on inflammatory cytokine production including TNF-alpha and IL-1beta reduction.
Current evidence for Trikatu comes primarily from animal studies rather than human clinical trials. Rat studies using alcoholic liver disease models showed improvements in liver enzymes and oxidative stress markers. Arthritis models in animals demonstrated reduced inflammatory markers TNF-alpha and IL-1beta. Human bioavailability studies focus mainly on individual components rather than the complete Trikatu formula, limiting clinical applicability.
Trikatu may cause gastrointestinal irritation, heartburn, or stomach upset in sensitive individuals due to its pungent nature. Piperine significantly enhances absorption of many medications including anticoagulants, anticonvulsants, and immunosuppressants, potentially leading to increased drug effects. Pregnancy and breastfeeding safety data is insufficient, warranting caution. Individuals with peptic ulcers or GERD should avoid use due to potential gastric irritation.
